Literature DB >> 9472659

The surface epithelium of recurrent infected palatine tonsils is rich in gammadelta T cells.

K Olofsson1, S Hellström, M L Hammarström.   

Abstract

Using a large panel of MoAbs in quantitative morphometric analysis of immunohistochemically stained tissue sections, we compared the frequency and distribution of immune cells in palatine tonsils from patients with recurrent tonsillitis (RT) and patients with idiopathic tonsillar hypertrophy (ITH). We found that differences between the two patient groups in leucocyte populations were limited to the surface epithelium, whereas the cellular composition of interfollicular and follicular areas was similar. Most intraepithelial lymphocytes were CD8+ T cells in both groups. However, the number of intraepithelial T cells was significantly higher in RT compared with ITH. This was due to a selective increase in the number of intraepithelial CD8+ gammadelta T cells utilizing Vdelta1 and Vgamma9. In both patient groups the majority of the intraepithelial gammadelta T cells expressed Vdelta1 and Vgamma9. Subepithelially, gammadelta T cells utilizing Vgamma9 dominated over cells utilizing Vgamma8, while equal proportions expressed Vdelta1 and Vdelta2. These results suggest that cells utilizing the otherwise rare combination Vdelta1/Vgamma9 in their T cell receptors (TCR) may constitute a major gammadelta T cell population in palatine tonsils and are probably reactive to antigens specific to the tonsillar milieu. Furthermore, they indicate that preferentially this gammadelta T cell subpopulation is involved in immune reactions within the surface epithelium in RT. We speculate that gammadelta T cells are involved in clearing infectious bacteria at the tonsillar surface and in limiting inflammatory responses in the tonsils. Both local expansion and infiltration of blood cells probably contribute to the high numbers of gammadelta T cells in RT patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472659      PMCID: PMC1904845          DOI: 10.1046/j.1365-2249.1998.00446.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  68 in total

1.  Bacteriology of tonsil surface and core in children.

Authors:  J B Surow; S D Handler; S A Telian; G R Fleisher; C C Baranak
Journal:  Laryngoscope       Date:  1989-03       Impact factor: 3.325

2.  Subpopulations of human peripheral T gamma delta lymphocytes.

Authors:  F Triebel; T Hercend
Journal:  Immunol Today       Date:  1989-06

Review 3.  gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

Authors:  S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

4.  Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans.

Authors:  R P Bucy; C L Chen; M D Cooper
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

Review 5.  In situ studies of the germinal center reaction.

Authors:  G Kelsoe
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

Review 6.  Life and death in germinal centers (redux).

Authors:  G Kelsoe
Journal:  Immunity       Date:  1996-02       Impact factor: 31.745

7.  Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes.

Authors:  S Porcelli; M B Brenner; J L Greenstein; S P Balk; C Terhorst; P A Bleicher
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

8.  Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions.

Authors:  R L Modlin; C Pirmez; F M Hofman; V Torigian; K Uyemura; T H Rea; B R Bloom; M B Brenner
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

Review 9.  Recognition by gamma/delta T cells.

Authors:  Y H Chien; R Jores; M P Crowley
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

10.  A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes.

Authors:  F Triebel; F Faure; F Mami-Chouaib; S Jitsukawa; A Griscelli; C Genevée; S Roman-Roman; T Hercend
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

View more
  6 in total

1.  Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor.

Authors:  Drew C Deniger; Kirsten Switzer; Tiejuan Mi; Sourindra Maiti; Lenka Hurton; Harjeet Singh; Helen Huls; Simon Olivares; Dean A Lee; Richard E Champlin; Laurence J N Cooper
Journal:  Mol Ther       Date:  2013-01-08       Impact factor: 11.454

2.  Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma.

Authors:  Brant A Inman; Xavier Frigola; Kimberley J Harris; Susan M Kuntz; Christine M Lohse; Bradley C Leibovich; Eugene D Kwon
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

3.  Functional characterization of T-cells from palatine tonsils in patients with chronic tonsillitis.

Authors:  Katharina Geißler; Robby Markwart; Robert Pascal Requardt; Cynthia Weigel; Katja Schubert; André Scherag; Ignacio Rubio; Orlando Guntinas-Lichius
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

4.  TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.

Authors:  Doaa Tawfik; Christopher Groth; Jan-Paul Gundlach; Matthias Peipp; Dieter Kabelitz; Thomas Becker; Hans-Heinrich Oberg; Anna Trauzold; Daniela Wesch
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

5.  Occurrence of IL-1, IL-10, CD25, CD40, and CD69 in the tissue of palatine tonsils.

Authors:  Przemysław Bant; Witold Owczarek; Kornel Szczygielski; Szczepan Cierniak; Joanna Kania; Dariusz Jurkiewicz
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.837

6.  Increased levels of S100A8/A9, IL-1ß and IL-18 as a novel biomarker for recurrent tonsillitis.

Authors:  Christoph Spiekermann; Alicia Seethaler; Annika McNally; Markus Stenner; Claudia Rudack; Johannes Roth; Thomas Vogl
Journal:  J Inflamm (Lond)       Date:  2021-06-29       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.